Crinetics Pharmaceuticals, Inc. - 8-K Filing
Crinetics Pharmaceuticals held its annual stockholder meeting on June 18, 2026, where three Class II directors were elected with votes for ranging from 73.45 million to 90.21 million shares; PricewaterhouseCoopers LLP was ratified as the independent auditor by a vote of approximately 101.68 million in favor; and advisory approval of executive compensation received about 91.66 million votes for. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $CRNX